Last week a select group of 50 innovators from the life sciences, healthcare, pharmaceutical, medical device and healthcare IT sectors were chosen to present their technolgies to an audience of Venture Capitalists, Angels, and Strategic Partners at the 2012 Life Sciences and Healthcare Venture Summit in New York City.
And a company from a province better known for its oil and gas innovation took home the top prize.
Edmonton’s Innovative Trauma Care (ITC) won best presenter and top innovator for its medical device for pre-hospital, point of injury medical care. ITC’s Tactical Use Skin Closure device (pictured) is a mechanical wound/skin closure device that quickly controls massive bleeding by closing the skin to create a temporary, contained hematoma until surgical repair.
Based out of the Edmonton Research Park (ERP), ITC’s vision is to design products that allow medics, soldiers and first responders to treat three of the most preventable causes of trauma deaths: massive bleeding, tension pneumothorax and airway obstruction.
Since its inception in April 2010, ITC’s innovative technology has come to life with the development of a functioning prototype and successful proof of the concept on live tissue.
ITC was co-founded by Dennis Filips (pictured) and Ian Atkinson who have invested $500K in the startup to date. ITC is in the process of raising $2 million in private financing for the first of three stages of product rollout.